| scholarly article | Q13442814 |
| P819 | ADS bibcode | 1994PNAS...91.4594P |
| P356 | DOI | 10.1073/PNAS.91.10.4594 |
| P932 | PMC publication ID | 43832 |
| P698 | PubMed publication ID | 8183954 |
| P5875 | ResearchGate publication ID | 15015217 |
| P2093 | author name string | Haffar OK | |
| Platt EJ | |||
| P2860 | cites work | Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release | Q24563651 |
| Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1 | Q24609814 | ||
| Myristoylation of gag proteins of HIV-1 plays an important role in virus assembly | Q28249070 | ||
| A synthetic HIV-1 protease inhibitor with antiviral activity arrests HIV-like particle maturation | Q28336106 | ||
| Amino acid substitutions within the matrix protein of type D retroviruses affect assembly, transport and membrane association of a capsid | Q35921966 | ||
| Myristylation site in Pr65gag is essential for virus particle formation by Moloney murine leukemia virus | Q36460089 | ||
| Mutations of RNA and protein sequences involved in human immunodeficiency virus type 1 packaging result in production of noninfectious virus | Q36804927 | ||
| Noninfectious human immunodeficiency virus type 1 mutants deficient in genomic RNA. | Q36809360 | ||
| Biochemical and immunological analysis of human immunodeficiency virus gag gene products p17 and p24. | Q36875767 | ||
| Myristylation is required for intracellular transport but not for assembly of D-type retrovirus capsids | Q36886315 | ||
| Fine-structure analyses of lipid-protein and protein-protein interactions of gag protein p19 of the avian sarcoma and leukemia viruses by cyanogen bromide mapping | Q36894685 | ||
| Viral RNA annealing activities of human immunodeficiency virus type 1 nucleocapsid protein require only peptide domains outside the zinc fingers | Q37111477 | ||
| The genetics of murine leukemia viruses. | Q40077796 | ||
| Assembly of Type C Oncornaviruses: A Model | Q40120488 | ||
| Identification of retrovirus matrix proteins by lipid-protein cross-linking | Q40275609 | ||
| A CAAX or a CAAL motif and a second signal are sufficient for plasma membrane targeting of ras proteins. | Q41083682 | ||
| Topogenic analysis of the human immunodeficiency virus type 1 envelope glycoprotein, gp160, in microsomal membranes | Q41562736 | ||
| Role of the gag and pol genes of human immunodeficiency virus in the morphogenesis and maturation of retrovirus-like particles expressed by recombinant vaccinia virus: an ultrastructural study | Q41662125 | ||
| Processing, assembly, and immunogenicity of human immunodeficiency virus core antigens expressed by recombinant vaccinia virus | Q41716133 | ||
| Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells | Q42073571 | ||
| Immunological and chemical analysis of P6, the carboxyl-terminal fragment of HIV P15. | Q44219513 | ||
| HIV-1 Gag mutants can dominantly interfere with the replication of the wild-type virus | Q45843803 | ||
| HIV-specific humoral and cellular immunity in rabbits vaccinated with recombinant human immunodeficiency virus-like gag-env particles | Q45854308 | ||
| Characterization of ribosomal frameshifting in HIV-1 gag-pol expression | Q46573916 | ||
| Form, function, and use of retroviral gag proteins | Q67961638 | ||
| Specific and saturable binding of pp60v-src to plasma membranes: evidence for a myristyl-src receptor | Q69353017 | ||
| Highly sensitive immunoadsorption procedure for detection of low-abundance proteins | Q70145502 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 5 | |
| P304 | page(s) | 4594-4598 | |
| P577 | publication date | 1994-05-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Characterization of human immunodeficiency virus type 1 Pr55gag membrane association in a cell-free system: requirement for a C-terminal domain | |
| P478 | volume | 91 |
| Q30442168 | A multistep, ATP-dependent pathway for assembly of human immunodeficiency virus capsids in a cell-free system |
| Q39699793 | A structurally disordered region at the C terminus of capsid plays essential roles in multimerization and membrane binding of the gag protein of human immunodeficiency virus type 1. |
| Q30447057 | Association of human immunodeficiency virus type 1 gag with membrane does not require highly basic sequences in the nucleocapsid: use of a novel Gag multimerization assay |
| Q33800960 | Basic residues in human immunodeficiency virus type 1 nucleocapsid promote virion assembly via interaction with RNA. |
| Q33647588 | Binding of human immunodeficiency virus type 1 Gag to membrane: role of the matrix amino terminus. |
| Q33780632 | Biochemical characterization of rous sarcoma virus MA protein interaction with membranes |
| Q24679629 | Differential membrane binding of the human immunodeficiency virus type 1 matrix protein |
| Q35857301 | Electrostatic interactions drive membrane association of the human immunodeficiency virus type 1 Gag MA domain |
| Q27642873 | Entropic switch regulates myristate exposure in the HIV-1 matrix protein |
| Q59360984 | HIV-1 Matrix Protein Interactions with tRNA: Implications for Membrane Targeting |
| Q39551677 | Human immunodeficiency virus type 1 protease triggers a myristoyl switch that modulates membrane binding of Pr55(gag) and p17MA. |
| Q33808429 | Human immunodeficiency virus type 1 virion density is not determined by nucleocapsid basic residues |
| Q24681117 | Inhibitors of human immunodeficiency virus type 1 zinc fingers prevent normal processing of gag precursors and result in the release of noninfectious virus particles |
| Q41275889 | Initial cleavage of the human immunodeficiency virus type 1 GagPol precursor by its activated protease occurs by an intramolecular mechanism |
| Q36483820 | Interaction between the human immunodeficiency virus type 1 Gag matrix domain and phosphatidylinositol-(4,5)-bisphosphate is essential for efficient gag membrane binding |
| Q34435902 | Membrane binding of human immunodeficiency virus type 1 matrix protein in vivo supports a conformational myristyl switch mechanism |
| Q33874447 | Membrane targeting properties of a herpesvirus tegument protein-retrovirus Gag chimera |
| Q35023995 | Mutation of dileucine-like motifs in the human immunodeficiency virus type 1 capsid disrupts virus assembly, gag-gag interactions, gag-membrane binding, and virion maturation |
| Q39642301 | Mutational analysis of the human immunodeficiency virus type 1 Vpu transmembrane domain that promotes the enhanced release of virus-like particles from the plasma membrane of mammalian cells. |
| Q33787084 | Relationship between human immunodeficiency virus type 1 Gag multimerization and membrane binding |
| Q33813747 | Reversion of a human immunodeficiency virus type 1 matrix mutation affecting Gag membrane binding, endogenous reverse transcriptase activity, and virus infectivity |
| Q34984031 | Structural basis for targeting HIV-1 Gag proteins to the plasma membrane for virus assembly. |
| Q39578928 | The I domain is required for efficient plasma membrane binding of human immunodeficiency virus type 1 Pr55Gag |
| Q37415605 | Total chemical synthesis of N-myristoylated HIV-1 matrix protein p17: structural and mechanistic implications of p17 myristoylation |
| Q34068037 | Virus maturation by budding |
Search more.